Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Minority Interest: 2024-2025

Historic Minority Interest for Ultragenyx Pharmaceutical (RARE) over the last 1 years, with Sep 2025 value amounting to $7.0 million.

  • Ultragenyx Pharmaceutical's Minority Interest changed negligibly% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $7.0 million for FY2024, which is N/A change from last year.
  • Per Ultragenyx Pharmaceutical's latest filing, its Minority Interest stood at $7.0 million for Q3 2025, which was down 0.00% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Ultragenyx Pharmaceutical's Minority Interest registered a high of $7.0 million during Q3 2024, and its lowest value of $7.0 million during Q3 2024.
  • For the 2-year period, Ultragenyx Pharmaceutical's Minority Interest averaged around $7.0 million, with its median value being $7.0 million (2025).